Clinical Trial Update: Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial [Phase 3]

View source ↗

Summary

This document describes a randomized Phase 3 trial comparing bevacizumab alone to bevacizumab plus triamcinolone for refractory diabetic macular edema, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 3 | Status: UNKNOWN